Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Data of Moderate to Severe Inflammatory Bowel Disease in Brazil: a Non-interventional, Multicenter Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life (RISE BR)

NCT02822235 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT02822235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02822235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Data of Moderate to Severe Inflammatory Bowel Disease in Brazil: a Non-interventional, Multicenter Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life (RISE BR)
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
October 11, 2016
Completion date
February 19, 2018
Enrollment
407 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel disease